Table 2.
Outcome scores in mean (range)
| Preop | 3 months | 6 months | 12 monthsa | |||||
|---|---|---|---|---|---|---|---|---|
| Group 1 | Group 2 | Group 1 | Group 2 | Group 1 | Group 2 | Group 1 | Group 2 | |
| CMS pain | 6.3 (0–10) | 7.0 (0–15) | 7.5 (5–10) | 13.7 (10–15) | 10.0 (5–10) | 10.0(5–15) | 13.3 (10–15) | 11.0 (0–15) |
| CMS activity | 7.0 (4–12) | 10.4 (4–14) | 5.0 (4–6) | 16.5 (15–19) | 9.3 (4–15) | 14.8(12–20) | 16.0 (10–20) | 16.4 (8–20) |
| CMS mobility | 17.5 (10–24) | 23.6 (8–36) | 10.0 (8–12) | 26.0 (20–30) | 14.5 (8–20) | 27.2(22–34) | 20.6 (18–26) | 30.8 (20–36) |
| CMS strength | 12.5 (5–25) | 9.46 (2–19) | 12.5 (5–20) | 9.65 (8–12) | 14.3 (5–22) | 10.4(4–18) | 19.7 (10–25) | 9.88 (2–17) |
| CMS total | 43.3 (31–32) | 49.0 (26–73) | 35.0 (28–42) | 65.9 (61–73) | 46.5 (28–67) | 62.0(51–69) | 69.7 (53–80) | 68.1 (30–81) |
| SST | 5.5 (1–8) | – | 4.75 (1–8) | – | 5.3 (2–7) | – | 6.3 (6–7) | – |
| WORC | 55.3 (36–52) | – | 43.3 (39–53) | – | 47.7 (32–60) | – | 60.3 (49–67) | – |
| VAS pain | 45.0 (30–70) | 60 (30–80) | 56.3 (20–80) | 27 (20–50) | 37.5 (10–65) | 38(20–60) | 16.7 (10–20) | 26 (10–80) |
| VAS disability | 53.3 (8–80) | 54 (20–10) | 65.0 (40–85) | 35 (30–40) | 46.3 (20–70) | 42 (30–60) | 40.0 (15–70) | 30 (10–80) |
| VAS satisfaction | – | – | 46.3 (40–50) | – | 43.8 (5–60) | – | 63.4 (45–85) | – |
Group 1, surgical treatment; group 2, non-surgical treatment
WORC depicted as a percentage of normal/maximum score
aResults of three out of four patients